Viewing Study NCT06786234


Ignite Creation Date: 2025-12-25 @ 2:27 AM
Ignite Modification Date: 2026-01-07 @ 9:51 AM
Study NCT ID: NCT06786234
Status: RECRUITING
Last Update Posted: 2025-07-09
First Post: 2025-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study to Assess STP938 as a Monotherapy in Adults With High Risk Essential Thrombocythaemia
Sponsor: Step Pharma, SAS
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module